Zaragoza, Spain

Adrián Velázquez Campoy

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adrián Velázquez Campoy: Innovator in Hyperphenylalaninemia Treatment

Introduction

Adrián Velázquez Campoy is a notable inventor based in Zaragoza, Spain. He has made significant contributions to the field of pharmacology, particularly in the treatment of metabolic disorders. His work focuses on innovative solutions for conditions such as hyperphenylalaninemia and phenylketonuria.

Latest Patents

Adrián holds a patent for "Compositions for the treatment of hyperphenylalaninemia." This invention relates to the use of specific compounds that act as pharmacological chaperones. These compounds have a stabilizing effect on the phenylalanine hydroxylase (PAH) enzyme, which is crucial for the prophylaxis and treatment of hyperphenylalaninemia (HPA) and phenylketonuria (PKU). The patent also covers pharmaceutical compositions containing these compounds and methods for treating HPA and related conditions.

Career Highlights

Adrián is affiliated with the Universidad de Zaragoza, where he conducts research and develops innovative treatments. His work has garnered attention for its potential impact on patients suffering from metabolic disorders. With 1 patent to his name, he continues to push the boundaries of medical science.

Collaborations

Adrián has collaborated with esteemed colleagues such as Ángel Pey Rodríguez and Aurora Martínez Ruiz. These partnerships have enhanced his research efforts and contributed to the advancement of treatment options in his field.

Conclusion

Adrián Velázquez Campoy is a pioneering inventor whose work in the treatment of hyperphenylalaninemia showcases the importance of innovation in addressing complex medical conditions. His contributions are vital for improving the lives of those affected by metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…